{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:49:49Z","timestamp":1790642989132,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10792-019-01189-3","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T07:56:44Z","timestamp":1570694204000},"page":"511-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies"],"prefix":"10.1007","volume":"40","author":[{"given":"Samira","family":"Heydarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiumars Nowroozpoor","family":"Dailami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Jafarzadehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8426-5924","authenticated-orcid":false,"given":"Mohsen","family":"Heirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbasali","family":"Yekta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monireh","family":"Mahjoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Khabazkhoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"1189_CR1","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199227396.001.0001","volume-title":"Oxford handbook of clinical haematology","author":"D Provan","year":"2009","unstructured":"Provan D, Singer CR, Baglin T, Dokal I (2009) Oxford handbook of clinical haematology. Oxford University Press, Oxford"},{"issue":"2","key":"1189_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","volume":"12","author":"A Cao","year":"2010","unstructured":"Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12(2):61","journal-title":"Genet Med"},{"issue":"9","key":"1189_CR3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","volume":"331","author":"NF Olivieri","year":"1994","unstructured":"Olivieri NF, Nathan DG, MacMillan JH et al (1994) Survival in medically treated patients with homozygous \u03b2-thalassemia. N Engl J Med 331(9):574\u2013578","journal-title":"N Engl J Med"},{"issue":"6","key":"1189_CR4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.preteyeres.2007.07.004","volume":"26","author":"X He","year":"2007","unstructured":"He X, Hahn P, Iacovelli J et al (2007) Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res 26(6):649\u2013673","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"1189_CR5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199409013310902","volume":"331","author":"GM Brittenham","year":"1994","unstructured":"Brittenham GM, Griffith PM, Nienhuis AW et al (1994) Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331(9):567\u2013573","journal-title":"N Engl J Med"},{"key":"1189_CR6","doi-asserted-by":"crossref","unstructured":"Bollig C, Schell LK, R\u00fccker G et al (2017) Deferasirox for managing iron overload in people with thalassaemia. Cochrane Database Syst Rev 8:CD007476","DOI":"10.1002\/14651858.CD007476.pub3"},{"issue":"14","key":"1189_CR7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM199504063321404","volume":"332","author":"NF Olivieri","year":"1995","unstructured":"Olivieri NF, Brittenham GM, Matsui D et al (1995) Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med 332(14):918\u2013922","journal-title":"N Engl J Med"},{"issue":"1","key":"1189_CR8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12886-016-0285-2","volume":"16","author":"A Liaska","year":"2016","unstructured":"Liaska A, Petrou P, Georgakopoulos CD et al (2016) \u03b2-Thalassemia and ocular implications: a systematic review. BMC Ophthalmol 16(1):102","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"1189_CR9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0002-9394(89)90864-7","volume":"108","author":"S Gartaganis","year":"1989","unstructured":"Gartaganis S, Ismiridis K, Papageorgiou O, Beratis NG, Papanastasiou D (1989) Ocular abnormalities in patients with \u03b2-thalassemia. Am J Ophthalmol 108(6):699\u2013703","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1189_CR10","first-page":"357","volume":"30","author":"A Gaba","year":"1998","unstructured":"Gaba A, D\u2019Souza P, Chandra J, Narayan S, Sen S (1998) Ocular changes in \u03b2-thalassemia. Ann Ophthalmol Glaucoma 30(6):357\u2013360","journal-title":"Ann Ophthalmol Glaucoma"},{"key":"1189_CR11","first-page":"519","volume":"11","author":"H Shahriari","year":"2006","unstructured":"Shahriari H, Ghasemzadeh F, Eshghi P, Masoomian B (2006) Ocular side effects of desferal in patients with \u03b2-thalassemia. Bina J Ophthalmol 11:519\u2013523","journal-title":"Bina J Ophthalmol"},{"issue":"4","key":"1189_CR12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajo.2006.04.030","volume":"142","author":"A Taher","year":"2006","unstructured":"Taher A, Bashshur Z, Shamseddeen WA et al (2006) Ocular findings among thalassemia patients. Am J Ophthalmol 142(4):704\u2013705","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1189_CR13","first-page":"928","volume":"4","author":"M Rahiminejad","year":"2009","unstructured":"Rahiminejad M, Rahiminejad S, Rahimi M et al (2009) Ocular complication and visual evoked potential in \u03b2-thalassemia patients on desferal therapy. Res J Biol Sci 4(8):928\u2013932","journal-title":"Res J Biol Sci"},{"issue":"2","key":"1189_CR14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0301-4738.60083","volume":"58","author":"R Taneja","year":"2010","unstructured":"Taneja R, Malik P, Sharma M, Agarwal MC (2010) Multiple transfused thalassemia major: ocular manifestations in a hospital-based population. Indian J Ophthalmol 58(2):125","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"1189_CR15","first-page":"11","volume":"5","author":"P Dewan","year":"2011","unstructured":"Dewan P, Gomber S, Chawla H, Rohatgi J (2011) Ocular changes in multi-transfused children with \u03b2-thalassaemia receiving desferrioxamine: a case-control study. S Afr J Child Health 5(1):11\u201314","journal-title":"S Afr J Child Health"},{"issue":"4","key":"1189_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1444-0938.2010.00579.x","volume":"94","author":"MH Nowroozzadeh","year":"2011","unstructured":"Nowroozzadeh MH, Kalantari Z, Namvar K, Meshkibaf MH (2011) Ocular refractive and biometric characteristics in patients with thalassaemia major. Clin Exp Optom 94(4):361\u2013366","journal-title":"Clin Exp Optom"},{"issue":"9","key":"1189_CR17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4103\/0301-4738.170986","volume":"63","author":"R Jafari","year":"2015","unstructured":"Jafari R, Heydarian S, Karami H et al (2015) Ocular abnormalities in multi-transfused beta-thalassemia patients. Indian J Ophthalmol 63(9):710","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"1189_CR18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.18203\/2349-3291.ijcp20171487","volume":"4","author":"D Kumble","year":"2017","unstructured":"Kumble D, Sekhon PK (2017) Ocular involvement in beta thalassemia major: a prospective study in an Indian cohort. Int J Contemp Pediatr 4(3):780\u2013782","journal-title":"Int J Contemp Pediatr"},{"issue":"7","key":"1189_CR19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12098-017-2339-8","volume":"84","author":"RH Merchant","year":"2017","unstructured":"Merchant RH, Punde H, Thacker N, Bhatt D (2017) Ophthalmic evaluation in beta-thalassemia. Indian J Pediatr 84(7):509\u2013514","journal-title":"Indian J Pediatr"},{"key":"1189_CR20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ophtha.2013.10.016","volume":"121","author":"G Barteselli","year":"2014","unstructured":"Barteselli G, Dell\u2019arti L, Finger RP et al (2014) The spectrum of ocular alterations in patients with beta-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum. Ophthalmology 121:709\u2013718","journal-title":"Ophthalmology"},{"issue":"1","key":"1189_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/1110-9173.201618","volume":"18","author":"AT Saif","year":"2017","unstructured":"Saif AT, Saif PS, Dabous O (2017) Fundus changes in thalassemia in Egyptian patients. Delta J Ophthalmol 18(1):20","journal-title":"Delta J Ophthalmol"},{"issue":"2","key":"1189_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2141.2004.05143.x","volume":"127","author":"E Voskaridou","year":"2004","unstructured":"Voskaridou E, Terpos E (2004) New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol 127(2):127\u2013139","journal-title":"Br J Haematol"},{"issue":"4","key":"1189_CR23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-2141.1998.01108.x","volume":"103","author":"C Jensen","year":"1998","unstructured":"Jensen C, Tuck S, Agnew J et al (1998) High prevalence of low bone mass in thalassaemia major. Br J Haematol 103(4):911\u2013915","journal-title":"Br J Haematol"},{"key":"1189_CR24","volume-title":"The thalassaemia syndromes","author":"DJ Weatherall","year":"2008","unstructured":"Weatherall DJ, Clegg JB (2008) The thalassaemia syndromes. Wiley, Hoboken"},{"issue":"2","key":"1189_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10792-015-0161-8","volume":"36","author":"S Heydarian","year":"2016","unstructured":"Heydarian S, Jafari R, Karami H (2016) Refractive errors and ocular biometry components in thalassemia major patients. Int Ophthalmol 36(2):267\u2013271","journal-title":"Int Ophthalmol"},{"issue":"1","key":"1189_CR26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1076\/ceyr.28.1.11.23491","volume":"28","author":"F Parentin","year":"2004","unstructured":"Parentin F, Tonini G, Perissutti P (2004) Refractive evaluation in children with growth defect. Curr Eye Res 28(1):11\u201315","journal-title":"Curr Eye Res"},{"issue":"4","key":"1189_CR27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000085732","volume":"219","author":"F Parentin","year":"2005","unstructured":"Parentin F, Perissutti P (2005) Congenital growth hormone deficiency and eye refraction: a longitudinal study. Ophthalmologica 219(4):226\u2013231","journal-title":"Ophthalmologica"},{"issue":"7","key":"1189_CR28","first-page":"e1","volume":"113","author":"DH Bourla","year":"1197","unstructured":"Bourla DH, Laron Z, Snir M, Lilos P, Weinberger D, Axer-Siegel R (1197) Insulinlike growth factor I affects ocular development: a study of untreated and treated patients with Laron syndrome. Ophthalmology 113(7):e1\u2013e5","journal-title":"Ophthalmology"},{"issue":"68","key":"1189_CR29","first-page":"42","volume":"17","author":"M Khalaj","year":"2009","unstructured":"Khalaj M, Mahyar A, Jahan Hashemi H, Godsi F (2009) Assessing the refractive errors in beta-thalassemia major patients. J Guilan Univ Med Sci 17(68):42\u201349","journal-title":"J Guilan Univ Med Sci"},{"issue":"2","key":"1189_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5301\/ejo.5000903","volume":"28","author":"RS Elkitkat","year":"2018","unstructured":"Elkitkat RS, El-Shazly AA, Ebeid WM, Deghedy MR (2018) Relation of anthropometric measurements to ocular biometric changes and refractive error in children with thalassemia. Eur J Ophthalmol 28(2):139\u2013143","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"1189_CR31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00003226-200310000-00002","volume":"22","author":"S Gartaganis","year":"2003","unstructured":"Gartaganis S, Georgakopoulos C, Exarchou A et al (2003) Alterations in conjunctival cytology and tear film dysfunction in patients with \u03b2-thalassemia. Cornea 22(7):591\u2013597","journal-title":"Cornea"},{"issue":"6","key":"1189_CR32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000208203","volume":"53","author":"A Arcasoy","year":"1975","unstructured":"Arcasoy A, Cavdar AO (1975) Changes of trace minerals (serum iron, zinc, copper and magnesium) in thalassemia. Acta Haematol 53(6):341\u2013346","journal-title":"Acta Haematol"},{"issue":"6","key":"1189_CR33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/10715769900300491","volume":"30","author":"C De Luca","year":"1999","unstructured":"De Luca C, Filosa A, Grandinetti M, Maggio F, Lamba M, Passi S (1999) Blood antioxidant status and urinary levels of catecholamine metabolites in \u03b2-thalassemia. Free Radic Res 30(6):453\u2013462","journal-title":"Free Radic Res"},{"issue":"6418","key":"1189_CR34","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.288.6418.668","volume":"288","author":"C Borgna-Pignatti","year":"1984","unstructured":"Borgna-Pignatti C, Cammareri V, De Stefano P, Magrini U (1984) The sicca syndrome in thalassaemia major. Br Med J (Clin Res Ed) 288(6418):668\u2013669","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"1189_CR35","first-page":"10","volume":"45","author":"C Popescu","year":"1998","unstructured":"Popescu C, Siganos D, Zanakis E, Padakis A (1998) The mechanism of cataract formation in persons with beta-thalassemia. Oftalmologia (Bucharest, Romania: 1990) 45(4):10\u201313","journal-title":"Oftalmologia (Bucharest, Romania: 1990)"},{"issue":"9","key":"1189_CR36","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jcrs.2007.05.011","volume":"33","author":"I Athanasiadis","year":"2007","unstructured":"Athanasiadis I, Konstantinidis A, Kyprianou I, Robinson R, Moschou V, Kouzi-Koliakos K (2007) Rapidly progressing bilateral cataracts in a patient with beta thalassemia and pellagra. J Cataract Refract Surg 33(9):1659\u20131661","journal-title":"J Cataract Refract Surg"},{"issue":"11","key":"1189_CR37","first-page":"1141","volume":"42","author":"V Dhawan","year":"2005","unstructured":"Dhawan V, KhR K, Marwaha R, Ganguly NK (2005) Antioxidant status in children with homozygous thalassemia. Indian Pediatr 42(11):1141\u20131145","journal-title":"Indian Pediatr"},{"issue":"5","key":"1189_CR38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.exer.2004.06.008","volume":"79","author":"S Marsili","year":"2004","unstructured":"Marsili S, Salganik RI, Albright CD et al (2004) Cataract formation in a strain of rats selected for high oxidative stress. Exp Eye Res 79(5):595\u2013612","journal-title":"Exp Eye Res"},{"issue":"4","key":"1189_CR39","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1444-0938.2009.00385.x","volume":"92","author":"M Mehdizadeh","year":"2009","unstructured":"Mehdizadeh M, Nowroozzadeh MH (2009) Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption. Clin Exp Optom 92(4):392\u2013394","journal-title":"Clin Exp Optom"},{"issue":"1","key":"1189_CR40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/08820538.2013.839811","volume":"29","author":"A Aksoy","year":"2014","unstructured":"Aksoy A, Aslan L, Aslankurt M et al (2014) Retinal fiber layer thickness in children with thalassemia major and iron deficiency anemia. Semin ophthalmol 29(1):22\u201326","journal-title":"Semin ophthalmol"},{"issue":"1","key":"1189_CR41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.survophthal.2015.08.005","volume":"61","author":"DL Bhoiwala","year":"2016","unstructured":"Bhoiwala DL, Dunaief JL (2016) Retinal abnormalities in \u03b2-thalassemia major. Surv Ophthalmol 61(1):33\u201350","journal-title":"Surv Ophthalmol"},{"key":"1189_CR42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10633-010-9236-z","volume":"121","author":"MA Genead","year":"2010","unstructured":"Genead MA, Fishman GA, Anastasakis A, Lindeman M (2010) Macular vitelliform lesion in desferrioxamine-related retinopathy. Doc Ophthalmol 121:161\u2013166","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"1189_CR43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12886-018-0911-2","volume":"18","author":"CD Georgakopoulos","year":"2018","unstructured":"Georgakopoulos CD, Tsapardoni F, Kostopoulou EV, Makri OE (2018) Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature. BMC Ophthalmol 18(1):246","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"1189_CR44","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00006982-200406000-00024","volume":"24","author":"CR Gonzales","year":"2004","unstructured":"Gonzales CR, Lin AP, Engstrom RE, Kreiger AE (2004) Bilateral vitelliform maculopathy and deferoxamine toxicity. Retina (Philadelphia, Pa) 24(3):464\u2013467","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"7","key":"1189_CR45","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/IAE.0000000000000073","volume":"34","author":"F Viola","year":"2014","unstructured":"Viola F, Barteselli G, Dell\u2019Arti L et al (2014) Multimodal imaging in deferoxamine retinopathy. Retina (Philadelphia, Pa) 34(7):1428\u20131438","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"2","key":"1189_CR46","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.survophthal.2008.12.006","volume":"54","author":"RP Finger","year":"2009","unstructured":"Finger RP, Issa PC, Ladewig MS et al (2009) Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol 54(2):272\u2013285","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"1189_CR47","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archopht.1957.00940010673005","volume":"58","author":"G Goodman","year":"1957","unstructured":"Goodman G, von Sallmann L, Holland MG (1957) Ocular manifestations of sickle-cell disease. AMA Arch Ophthalmol 58(5):655\u2013682","journal-title":"AMA Arch Ophthalmol"},{"issue":"1","key":"1189_CR48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood.V99.1.30","volume":"99","author":"A Aessopos","year":"2002","unstructured":"Aessopos A, Farmakis D, Loukopoulos D (2002) Elastic tissue abnormalities resembling pseudoxanthoma elasticum in \u03b2-thalassemia and the sickling syndromes. Blood 99(1):30\u201335","journal-title":"Blood"},{"issue":"5","key":"1189_CR49","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1046\/j.1365-2141.2003.04484.x","volume":"122","author":"N Hamlin","year":"2003","unstructured":"Hamlin N, Beck K, Bacchelli B, Cianciulli P, Pasquali-Ronchetti I, Le Saux O (2003) Acquired Pseudoxanthoma elasticum-like syndrome in \u03b2-thalassaemia patients. Br J Haematol 122(5):852\u2013854","journal-title":"Br J Haematol"},{"issue":"3","key":"1189_CR50","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1074\/jbc.M409897200","volume":"280","author":"S Bunda","year":"2005","unstructured":"Bunda S, Kaviani N, Hinek A (2005) Fluctuations of intracellular iron modulate elastin production. J Biol Chem 280(3):2341\u20132351","journal-title":"J Biol Chem"},{"issue":"2","key":"1189_CR51","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ajpath.2010.10.004","volume":"178","author":"L Martin","year":"2011","unstructured":"Martin L, Douet V, VanWart CM, Heller MB, Le Saux O (2011) A mouse model of \u03b2-thalassemia shows a liver-specific down-regulation of ABCC6 expression. Am J Pathol 178(2):774\u2013783","journal-title":"Am J Pathol"},{"issue":"2","key":"1189_CR52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.jid.5700065","volume":"126","author":"Q Jiang","year":"2006","unstructured":"Jiang Q, Matsuzaki Y, Li K, Uitto J (2006) Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene. J Investig Dermatol 126(2):325\u2013335","journal-title":"J Investig Dermatol"},{"key":"1189_CR53","first-page":"81","volume":"5","author":"I Georgalas","year":"2009","unstructured":"Georgalas I, Papaconstantinou D, Koutsandrea C et al (2009) Angioid streaks, clinical course, complications, and current therapeutic management. Ther Clin Risk Manag 5:81","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"1189_CR54","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0002-9394(14)73300-8","volume":"108","author":"A Aessopos","year":"1989","unstructured":"Aessopos A, Stamatelos G, Savvides P et al (1989) Angioid streaks in homozygous \u03b2-thalassemia. Am J Ophthalmol 108(4):356\u2013359","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1189_CR55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjo.67.1.29","volume":"67","author":"J Gibson","year":"1983","unstructured":"Gibson J, Chaudhuri P, Rosenthal A (1983) Angioid streaks in a case of beta thalassaemia major. Br J Ophthalmol 67(1):29","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1189_CR56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/bjo.72.4.303","volume":"72","author":"FP Kinsella","year":"1988","unstructured":"Kinsella FP, Mooney DJ (1988) Angioid streaks in beta thalassaemia minor. Br J Ophthalmol 72(4):303\u2013304","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"1189_CR57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12185-007-0014-y","volume":"87","author":"A Aessopos","year":"2008","unstructured":"Aessopos A, Floudas CS, Kati M et al (2008) Loss of vision associated with angioid streaks in \u03b2-thalassemia intermedia. Int J Hematol 87(1):35\u201338","journal-title":"Int J Hematol"},{"issue":"7","key":"1189_CR58","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ophtha.2009.11.008","volume":"117","author":"PC Issa","year":"2010","unstructured":"Issa PC, Finger RP, G\u00f6tting C, Hendig D, Holz FG, Scholl HP (2010) Centrifugal fundus abnormalities in pseudoxanthoma elasticum. Ophthalmology 117(7):1406\u20131414","journal-title":"Ophthalmology"},{"issue":"3","key":"1189_CR59","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.eye.6700352","volume":"17","author":"C Incorvaia","year":"2003","unstructured":"Incorvaia C, Parmeggiani F, Costagliola C, Perri P, D\u2019Angelo S, Sebastiani A (2003) Quantitative evaluation of the retinal venous tortuosity in chronic anaemic patients affected by \u03b2-thalassaemia major. Eye 17(3):324","journal-title":"Eye"},{"issue":"1","key":"1189_CR60","first-page":"23","volume":"13","author":"R Sorcinelli","year":"1990","unstructured":"Sorcinelli R, Sitzia A, Figus A, Lai M (1990) Ocular findings in beta-thalassemia. Metab Pediatr Syst Ophthalmol (New York, NY: 1985) 13(1):23\u201325","journal-title":"Metab Pediatr Syst Ophthalmol (New York, NY: 1985)"},{"issue":"35","key":"1189_CR61","doi-asserted-by":"crossref","first-page":"12413","DOI":"10.1073\/pnas.0503460102","volume":"102","author":"G Moiseyev","year":"2005","unstructured":"Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma J-X (2005) RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc Natl Acad Sci 102(35):12413\u201312418","journal-title":"Proc Natl Acad Sci"},{"issue":"4\u20136","key":"1189_CR62","first-page":"174","volume":"111","author":"J B\u0142asiak","year":"2009","unstructured":"B\u0142asiak J, Sk\u0142odowska A, Uli\u0144ska M, Szaflik J (2009) Iron and age-related macular degeneration. Klin Oczna 111(4\u20136):174\u2013177","journal-title":"Klin Oczna"},{"key":"1189_CR63","doi-asserted-by":"crossref","unstructured":"Mehta S, Dunaief JL (2012) The role of iron in retinal diseases. In: Studies on retinal and choroidal disorders. Humana Press, pp 259\u2013275","DOI":"10.1007\/978-1-61779-606-7_12"},{"issue":"8343","key":"1189_CR64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(83)90170-8","volume":"322","author":"S Davies","year":"1983","unstructured":"Davies S, Hungerford J, Arden G, Marcus R, Miller M, Huehns E (1983) Ocular toxicity of high-dose intravenous desferrioxamine. Lancet 322(8343):181\u2013184","journal-title":"Lancet"},{"issue":"14","key":"1189_CR65","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198604033141402","volume":"314","author":"NF Olivieri","year":"1986","unstructured":"Olivieri NF, Buncic JR, Chew E et al (1986) Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N Engl J Med 314(14):869\u2013873","journal-title":"N Engl J Med"},{"key":"1189_CR66","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/IAE.0b013e3181679f67","volume":"28","author":"JS Baath","year":"2008","unstructured":"Baath JS, Lam WC, Kirby M, Chun A (2008) Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population. Retina (Philadelphia, Pa) 28:894\u2013899","journal-title":"Retina (Philadelphia, Pa)"},{"key":"1189_CR67","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0161-6420(01)00947-2","volume":"109","author":"R Haimovici","year":"2002","unstructured":"Haimovici R, D\u2019Amico DJ, Gragoudas ES, Sokol S (2002) The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology 109:164\u2013171","journal-title":"Ophthalmology"},{"issue":"1","key":"1189_CR68","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2415-14-88","volume":"14","author":"C-H Wu","year":"2014","unstructured":"Wu C-H, Yang C-P, Lai C-C, Wu W-C, Chen Y-H (2014) Deferoxamine retinopathy: spectral domain-optical coherence tomography findings. BMC Ophthalmol 14(1):88","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"1189_CR69","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/ICB.0000000000000059","volume":"8","author":"R Gelman","year":"2014","unstructured":"Gelman R, Kiss S, Tsang SH (2014) Multimodal imaging in a case of deferoxamine induced maculopathy. Retin Cases Brief Rep 8(4):306","journal-title":"Retin Cases Brief Rep"},{"issue":"2","key":"1189_CR70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/ICB.0000000000000013","volume":"8","author":"L Van Bol","year":"2014","unstructured":"Van Bol L, Alami A, Benghiat FS, Rasquin F (2014) Spectral domain optical coherence tomography findings in early deferoxamine maculopathy: report of two cases. Retin Cases Brief Rep 8(2):97\u2013102","journal-title":"Retin Cases Brief Rep"},{"key":"1189_CR71","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2147\/OPTH.S35627","volume":"6","author":"M Eleftheriadou","year":"2012","unstructured":"Eleftheriadou M, Theodossiadis P, Rouvas A, Alonistiotis D, Theodossiadis G (2012) New optical coherence tomography fundus findings in a case of beta-thalassemia. Clin Ophthalmol (Auckland, NZ) 6:2119","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"4","key":"1189_CR72","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/0301-4738.98714","volume":"60","author":"S Simon","year":"2012","unstructured":"Simon S, Athanasiov PA, Jain R, Raymond G, Gilhotra JS (2012) Desferrioxamine-related ocular toxicity: a case report. Indian J Ophthalmol 60(4):315","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"1189_CR73","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.ophtha.2012.01.039","volume":"119","author":"F Viola","year":"2012","unstructured":"Viola F, Barteselli G, Dell\u2019Arti L et al (2012) Abnormal fundus autofluorescence results of patients in long-term treatment with deferoxamine. Ophthalmology 119(8):1693\u20131700","journal-title":"Ophthalmology"},{"issue":"4","key":"1189_CR74","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ajh.20090","volume":"76","author":"A Arora","year":"2004","unstructured":"Arora A, Wren S, Gregory Evans K (2004) Desferrioxamine related maculopathy: a case report. Am J Hematol 76(4):386\u2013388","journal-title":"Am J Hematol"},{"key":"1189_CR75","doi-asserted-by":"crossref","unstructured":"Meerpohl JJ, Antes G, R\u00fccker G et al (2012) Deferasirox for managing iron overload in people with thalassaemia. Cochrane Database Syst Rev (2)","DOI":"10.1002\/14651858.CD007476.pub2"},{"issue":"5","key":"1189_CR76","first-page":"795","volume":"3","author":"R Galanello","year":"2007","unstructured":"Galanello R (2007) Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective. Ther Clin Risk Manag 3(5):795","journal-title":"Ther Clin Risk Manag"},{"key":"1189_CR77","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1167\/iovs.14-14568","volume":"55","author":"D Song","year":"2014","unstructured":"Song D, Zhao L, Li Y et al (2014) The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice. Invest Ophthalmol Vis Sci 55:4525\u20134532","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1189_CR78","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1034\/j.1600-0420.2000.078005512.x","volume":"78","author":"SP Gartaganis","year":"2000","unstructured":"Gartaganis SP, Zoumbos N, Koliopoulos JX, Mela EK (2000) Contrast sensitivity function in patients with beta-thalassemia major. Acta Ophthalmol Scand 78(5):512\u2013515","journal-title":"Acta Ophthalmol Scand"},{"key":"1189_CR79","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.optom.2018.01.002","volume":"12","author":"A Ghazanfari","year":"2018","unstructured":"Ghazanfari A, Jafarzadehpour E, Heydarian S, Dailami KN, Karami H (2018) Comparison of contrast sensitivity in \u03b2-thalassemia patients treated by deferoxamine or deferasirox. J Optom 12:168\u2013173","journal-title":"J Optom"},{"key":"1189_CR80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1874364101004010039","volume":"4","author":"G Spyridon","year":"2010","unstructured":"Spyridon G, Ioannis A, Nikolaos C et al (2010) Contrast sensitivity in patients with beta-thalassemia major and sickle cell disease under regular transfusions and treatment with desferrioxamine. Open Ophthalmol J 4:39","journal-title":"Open Ophthalmol J"},{"issue":"10","key":"1189_CR81","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0161-6420(83)34407-9","volume":"90","author":"D Regan","year":"1983","unstructured":"Regan D, Neima D (1983) Low-contrast letter charts as a test of visual function. Ophthalmology 90(10):1192\u20131200","journal-title":"Ophthalmology"},{"issue":"12","key":"1189_CR82","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/S0161-6420(98)91235-0","volume":"105","author":"RL Woods","year":"1998","unstructured":"Woods RL, Tregear SJ, Mitchell RA (1998) Screening for ophthalmic disease in older subjects using visual acuity and contrast sensitivity1. Ophthalmology 105(12):2318\u20132326","journal-title":"Ophthalmology"},{"key":"1189_CR83","volume-title":"Electrodiagnosis in clinical neurology","author":"MJ Aminoff","year":"2012","unstructured":"Aminoff MJ (2012) Electrodiagnosis in clinical neurology. Elsevier, Amsterdam"},{"issue":"3","key":"1189_CR84","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archopht.1962.00960030373012","volume":"68","author":"G Arden","year":"1962","unstructured":"Arden G, Fojas M (1962) Electrophysiological abnormalities in pigmentary degenerations of the retina: assessment of value and basis. Arch Ophthalmol 68(3):369\u2013389","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"1189_CR85","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0039-6257(00)00125-9","volume":"45","author":"HP Scholl","year":"2000","unstructured":"Scholl HP, Zrenner E (2000) Electrophysiology in the investigation of acquired retinal disorders. Surv Ophthalmol 45(1):29\u201347","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"1189_CR86","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00417-017-3650-9","volume":"255","author":"M Dettoraki","year":"2017","unstructured":"Dettoraki M, Kattamis A, Ladas I et al (2017) Electrophysiological assessment for early detection of retinal dysfunction in beta-thalassemia major patients. Graefe\u2019s Arch Clin Exp Ophthalmol 255(7):1349\u20131358","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"1","key":"1189_CR87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.braindev.2005.03.006","volume":"28","author":"M Economou","year":"2006","unstructured":"Economou M, Zafeiriou DI, Kontopoulos E et al (2006) Neurophysiologic and intellectual evaluation of beta-thalassemia patients. Brain Dev 28(1):14\u201318","journal-title":"Brain Dev"},{"issue":"6","key":"1189_CR88","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/IAE.0000000000001315","volume":"37","author":"AA El-Shazly","year":"2017","unstructured":"El-Shazly AA, Ebeid WM, Elkitkat RS, Deghedy MR (2017) Electroretinographic and visual-evoked potential changes in relation to chelation modality in children with thalassemia. Retina (Philadelphia, Pa) 37(6):1168\u20131175","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"1","key":"1189_CR89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000309871","volume":"196","author":"C Gelmi","year":"1988","unstructured":"Gelmi C, Borgna-Pignatti C, Franchin S, Tacchini M, Trimarchi F (1988) Electroretinographic and visual-evoked potential abnormalities in patients with beta-thalassemia major. Ophthalmologica 196(1):29\u201334","journal-title":"Ophthalmologica"},{"issue":"4","key":"1189_CR90","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/088307389300800407","volume":"8","author":"V Wong","year":"1993","unstructured":"Wong V, Li A, Lee A (1993) Neurophysiologic study of \u03b2-thalassemia patients. J Child Neurol 8(4):330\u2013335","journal-title":"J Child Neurol"},{"issue":"5","key":"1189_CR91","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0887-8994(98)00004-6","volume":"18","author":"DI Zafeiriou","year":"1998","unstructured":"Zafeiriou DI, Kousi AA, Tsantali CT et al (1998) Neurophysiologic evaluation of long-term desferrioxamine therapy in beta-thalassemia patients. Pediatr Neurol 18(5):420\u2013424","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1189_CR92","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/adc.63.3.250","volume":"63","author":"S De Virgiliis","year":"1988","unstructured":"De Virgiliis S, Congia M, Turco M et al (1988) Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia. Arch Dis Child 63(3):250\u2013255","journal-title":"Arch Dis Child"},{"issue":"2","key":"1189_CR93","first-page":"131","volume":"76","author":"M Marciani","year":"1991","unstructured":"Marciani M, Cianciulli P, Stefani N et al (1991) Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function. Haematologica 76(2):131\u2013134","journal-title":"Haematologica"},{"issue":"4","key":"1189_CR94","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/00006123-199804000-00134","volume":"42","author":"B Aarabi","year":"1998","unstructured":"Aarabi B, Haghshenas M, Rakeii V (1998) Visual failure caused by suprasellar extramedullary hematopoiesis in beta thalassemia: case report. Neurosurgery 42(4):922\u2013925","journal-title":"Neurosurgery"},{"issue":"10","key":"1189_CR95","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/jnnp.2003.024794","volume":"75","author":"E Stamboulis","year":"2004","unstructured":"Stamboulis E, Vlachou N, Drossou-Servou M et al (2004) Axonal sensorimotor neuropathy in patients with \u03b2-thalassaemia. J Neurol Neurosurg Psychiatry 75(10):1483\u20131486","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"1189_CR96","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/bjo.68.12.873","volume":"68","author":"G Arden","year":"1984","unstructured":"Arden G, Wonke B, Kennedy C, Huehns E (1984) Ocular changes in patients undergoing long-term desferrioxamine treatment. Br J Ophthalmol 68(12):873\u2013877","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1189_CR97","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1001728512515","volume":"96","author":"C Jiang","year":"1998","unstructured":"Jiang C, Hansen RM, Gee BE, Kurth SS, Fulton AB (1998) Rod and rod mediated function in patients with \u03b2-thalassemia major. Doc Ophthalmol 96(4):333\u2013346","journal-title":"Doc Ophthalmol"},{"issue":"4","key":"1189_CR98","first-page":"153","volume":"20","author":"R Orton","year":"1985","unstructured":"Orton R, Sulh H (1985) Ocular and auditory toxicity of long-term, high-dose subcutaneous deferoxamine therapy. Can J Ophthalmol 20(4):153\u2013156","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"1189_CR99","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0161-6420(01)00947-2","volume":"109","author":"R Haimovici","year":"2002","unstructured":"Haimovici R, D\u2019Amico DJ, Gragoudas ES, Sokol S, Group DRS (2002) The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology 109(1):164\u2013171","journal-title":"Ophthalmology"},{"issue":"11","key":"1189_CR100","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ndt\/5.11.945","volume":"5","author":"M Ravelli","year":"1990","unstructured":"Ravelli M, Scaroni P, Mombelloni S et al (1990) Acute visual disorders in patients on regular dialysis given desferrioxamine as a test. Nephrol Dial Transpl 5(11):945\u2013949","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"1189_CR101","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0008-4182(04)80031-0","volume":"39","author":"PJ Kertes","year":"2004","unstructured":"Kertes PJ, Lee TK, Coupland SG (2004) The utility of multifocal electroretinography in monitoring drug toxicity: deferoxamine retinopathy. Can J Ophthalmol 39(6):656\u2013661","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"1189_CR102","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bjo.37.6.353","volume":"37","author":"C Rudd","year":"1953","unstructured":"Rudd C, Evans PJ, Peeney A (1953) Ocular complications in thalassaemia minor. Br J Ophthalmol 37(6):353","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1189_CR103","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200008033430503","volume":"343","author":"E Angelucci","year":"2000","unstructured":"Angelucci E, Brittenham GM, Mclaren CE et al (2000) Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 343(5):327\u2013331","journal-title":"N Engl J Med"},{"issue":"3","key":"1189_CR104","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOH.0b013e32835f5a5c","volume":"20","author":"KM Musallam","year":"2013","unstructured":"Musallam KM, Cappellini MD, Taher AT (2013) Iron overload in \u03b2-thalassemia intermedia: an emerging concern. Curr Opin Hematol 20(3):187\u2013192","journal-title":"Curr Opin Hematol"},{"key":"1189_CR105","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0268-960X(12)70006-1","volume":"26","author":"KM Musallam","year":"2012","unstructured":"Musallam KM, Cappellini MD, Wood JC, Taher AT (2012) Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. Blood Rev 26:S16\u2013S19","journal-title":"Blood Rev"},{"issue":"1","key":"1189_CR106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2141.2001.02482.x","volume":"112","author":"D Tavazzi","year":"2001","unstructured":"Tavazzi D, Duca L, Graziadei G, Comino A, Fiorelli G, Cappellini MD (2001) Membrane-bound iron contributes to oxidative damage of \u03b2-thalassaemia intermedia erythrocytes. Br J Haematol 112(1):48\u201350","journal-title":"Br J Haematol"},{"issue":"4","key":"1189_CR107","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08820539809056054","volume":"13","author":"M Varano","year":"1998","unstructured":"Varano M, Scassa C (1998) Scanning laser ophthalmoscope microperimetry. Semin ophthalmol 13(4):203\u2013209","journal-title":"Semin ophthalmol"},{"issue":"12","key":"1189_CR108","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1167\/iovs.09-3541","volume":"50","author":"PC Issa","year":"2009","unstructured":"Issa PC, Finger RP, Holz FG, Scholl HP (2009) Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci 50(12):5913\u20135918","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01189-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-019-01189-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01189-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T19:08:32Z","timestamp":1602184112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-019-01189-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1007\/s10792-019-01189-3","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"17 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}